Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients

Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination, potentially caused by mycophenolate (MPA) immunosuppression. Recent data from patients with autoimmune disorders suggest that temporary MPA hold might greatly improve booster vaccination outcomes. We applied...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrezenmeier, Eva, Rincon-Arevalo, Hector, Jens, Annika, Stefanski, Ana-Luisa, Hammett, Charlotte, Osmanodja, Bilgin, Koch, Nadine, Zukunft, Bianca, Beck, Julia, Oellerich, Michael, Proß, Vanessa, Stahl, Carolin, Choi, Mira, Bachmann, Friederike, Liefeldt, Lutz, Glander, Petra, Schütz, Ekkehard, Bornemann-Kolatzki, Kirsten, López del Moral, Covadonga, Schrezenmeier, Hubert, Ludwig, Carolin, Jahrsdörfer, Bernd, Eckardt, Kai-Uwe, Lachmann, Nils, Kotsch, Katja, Dörner, Thomas, Halleck, Fabian, Sattler, Arne, Budde, Klemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090237/
https://www.ncbi.nlm.nih.gov/pubmed/35349490
http://dx.doi.org/10.1172/jci.insight.157836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090237/
https://www.ncbi.nlm.nih.gov/pubmed/35349490
http://dx.doi.org/10.1172/jci.insight.157836

Ejemplares similares